Study List

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Report Bug
Study List
You are on Page 765 of 776:
755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775

Clinical Studies

NCT Number Gene Therapy Sponsor Status Brief Title Phase View
NCT00044460 GlaxoSmithKline COMPLETED Efficacy and Safety In Poorly Controlled Type 2 Diabetics PHASE4 View
NCT00044434 National Institute on Alcohol Abuse and Alcoholism (NIAAA) COMPLETED Bupropion as a Smoking Cessation Aid in Alcoholics PHASE4 View
NCT00044395 Eli Lilly and Company COMPLETED Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes PHASE3 View
NCT00044369 National Institute of Environmental Health Sciences (NIEHS) COMPLETED Role of the Toxic Metal Cadmium in the Mechanism Producing Infertility With a Varicocele View
NCT00044356 Vical COMPLETED Phase II Trial of Allovectin-7® for Metastatic Melanoma PHASE2 View
NCT00044304 National Institute of Allergy and Infectious Diseases (NIAID) RECRUITING Tyrosine Kinase Inhibition to Treat Myeloid Hypereosinophilic Syndrome PHASE2 View
NCT00044200 National Institute of Neurological Disorders and Stroke (NINDS) COMPLETED Positron Emission Tomography (PET) to Study Brain Signaling View
NCT00044135 Triangle Pharmaceuticals UNKNOWN A Safety Study to Evaluate 12 Weeks of Treatment with Clevudine in Patients Infected with Hepatitis B Virus. PHASE2 View
NCT00044057 Astellas Pharma Inc COMPLETED A Study to Evaluate the Effects of YM872 on Brain Function and Disability When Administered in Combination With Alteplase (Tissue Plasminogen Activator) PHASE2 View
NCT00044018 Celgene COMPLETED CDC-501 Therapy in Relapsed or Refractory Multiple Myeloma PHASE2 View
NCT00044005 Sumitomo Pharma America, Inc. COMPLETED Safety and Tolerability Study of Drug to Treat Schizophrenia PHASE2 View
NCT00043992 National Institute of Environmental Health Sciences (NIEHS) COMPLETED Outdoor Allergen Exposure, Sensitivity, and Acute Asthma View
NCT00043966 Abbott COMPLETED Study of Lopinavir, Ritonavir, Tenofovir and Emtricitabine in HIV-Infected Antiretroviral Naïve Subjects PHASE3 View
NCT00043927 GlaxoSmithKline COMPLETED Extensive Small Cell Lung Cancer Treatment Using An Investigational Drug Plus Chemotherapy In Chemotherapy-Naive Adults PHASE3 View
NCT00043758 Otsuka Pharmaceutical Development & Commercialization, Inc. COMPLETED Multicenter, Randomized, Double-Blind, Placebo Controlled, Efficacy Study on the Effects of Tolvaptan on Left Ventricular Dilatation in Congestive Heart Failure Patients PHASE2 View
NCT00043732 Scios, Inc. COMPLETED Safety Study of SCIO-469 to Treat Patients With Active Rheumatoid Arthritis Receiving Methotrexate PHASE2 View
NCT00043706 Positive Gene Therapy Genzyme, a Sanofi Company COMPLETED Safety, Tolerability, and Pharmacokinetics of CAT-192 (Human Anti-TGF-Beta1 Monoclonal Antibody) in Patients With Early Stage Diffuse Systemic Sclerosis PHASE1 View
NCT00043693 Dartmouth-Hitchcock Medical Center COMPLETED Family Intervention for Mental Illness and Substance Abuse NA View
NCT00043667 National Eye Institute (NEI) COMPLETED Daclizumab Injections to Treat Non-Infectious Sight-Threatening Uveitis PHASE2 View
NCT00043602 University of Iowa COMPLETED Clinician Managed Interpersonal Psychotherapy EARLY_PHASE1 View
NCT00043550 University of Pennsylvania COMPLETED Treatments for Depression: Drug Versus Psychotherapy PHASE3 View
NCT00043459 Tularik TERMINATED Study of T900607-Sodium in Previously Treated Patients With Non-Hodgkin's Lymphoma. PHASE2 View
NCT00043433 Tularik UNKNOWN Study of T900607-Sodium in Chemotherapy Naive Patients With Hepatocellular Carcinoma. PHASE2 View
NCT00043420 Pfizer COMPLETED CPG 7909 in Patients With Cutaneous T-Cell Lymphoma PHASE1 View
NCT00043394 Pfizer COMPLETED CPG 7909 Plus Herceptin® In Patients With Metastatic Breast Cancer PHASE2 View
NCT00043368 Pfizer COMPLETED PF-3512676 (CPG 7909) Injection For Patients Who Completed An Oncology Study Using PF-3512676 (CPG 7909) PHASE2 View
NCT00043316 InterMune COMPLETED Interferon Gamma-1b by Inhalation for the Treatment of Patients With Cystic Fibrosis PHASE1 View
NCT00043303 InterMune COMPLETED Safety and Efficacy Study of Interferon Gamma-1b in Hepatitis C Patients With Liver Fibrosis or Cirrhosis PHASE2 View
NCT00043212 Northwest Biotherapeutics WITHDRAWN Study of a Drug [DCVax (tm)-Prostate] to Treat Prostate Cancer When Hormone Therapy is no Longer Effective. PHASE3 View
NCT00043134 Positive Gene Therapy European Organisation for Research and Treatment of Cancer - EORTC UNKNOWN Low-Dose Decitabine Compared With Standard Supportive Care in Treating Older Patients With Myelodysplastic Syndrome PHASE3 View
NCT00043095 Positive Gene Therapy Memorial Sloan Kettering Cancer Center COMPLETED BMS-247550 and Gemcitabine in Treating Patients With Advanced Solid Tumors PHASE1 View
NCT00043069 Alliance for Clinical Trials in Oncology COMPLETED Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate Cancer PHASE3 View
NCT00043004 European Organisation for Research and Treatment of Cancer - EORTC TERMINATED Chemotherapy and Bevacizumab With or Without Radiofrequency Ablation in Treating Unresectable Liver Metastases in Patients With Colorectal Cancer PHASE2 View
NCT00042861 National Cancer Institute (NCI) COMPLETED UCN-01, Fluorouracil, and Leucovorin in Treating Patients With Metastatic or Unresectable Solid Tumors PHASE1 View
NCT00042835 National Cancer Institute (NCI) TERMINATED Erlotinib and Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Inoperable Stage III Non-Small Cell Lung Cancer PHASE1 View
NCT00042718 Johnson & Johnson Pharmaceutical Research & Development, L.L.C. COMPLETED A Study of the Effectiveness and Safety of High Dose, Short-course Levofloxacin in the Treatment of Acute Bacterial Exacerbation (Worsening) of Chronic Bronchitis. PHASE3 View
NCT00042705 National Institute of Environmental Health Sciences (NIEHS) COMPLETED Asthma Severity in Children and Environmental Agents View
NCT00042692 National Institute of Environmental Health Sciences (NIEHS) COMPLETED Catechol Thioethers in Parkinson's Disease View
NCT00042666 Eli Lilly and Company COMPLETED A Study of Oral LY317615 in Relapsed or Refractory Diffuse Large B-Cell Lymphomas. PHASE2 View
NCT00042458 AstraZeneca COMPLETED Evaluation of Dose-titration of Pramlintide During Initiation of Therapy in Patients Trying to Improve Glucose Control PHASE3 View
NCT00042432 Amgen COMPLETED Study for Secondary Hyperparathyroidism in Chronic Renal Insufficiency Patients PHASE2 View
NCT00042393 Gilead Sciences APPROVED_FOR_MARKETING An Open-Label Program of Adefovir Dipivoxil in the Treatment of Patients With Lamivudine-Resistant Chronic Hepatitis B With Limited Treatment Options View
NCT00042367 Baylor College of Medicine COMPLETED Study of Systemic and Spinal Chemotherapy Followed by Radiation for Infants With Brain Tumors NA View
NCT00042302 QLT Inc. TERMINATED A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase III Study of Tariquidar + Paclitaxel/Carboplatin as First-Line Therapy in Non-Small Cell Lung Cancer (NSCLC) PHASE3 View
NCT00042250 M.D. Anderson Cancer Center COMPLETED IUdR/BUdR Cell Cycle Labelling NA View
NCT00042159 Yale University COMPLETED Transcranial Magnetic Stimulation (TMS) Treatment for Patients With Persistent Auditory Hallucinations NA View
NCT00042133 National Institute of Environmental Health Sciences (NIEHS) COMPLETED Socio-economic Status and Age-related Disability in a Biracial Community View
NCT00042120 National Institute of Environmental Health Sciences (NIEHS) COMPLETED Farming and Movement Evaluation Study (FAME) View
NCT00042094 DynPort Vaccine Company LLC, A GDIT Company COMPLETED Study of Reactogenicity, Safety, Immunogenicity, and Pock Lesion Formation of a Cell-Cultured Smallpox Vaccine Compared to Dryvax® PHASE1 View
NCT00042068 Boehringer Ingelheim COMPLETED A Multi-Center Trial to Compare Three Doses of Meloxicam and Placebo in Patients With Rheumatoid Arthritis PHASE3 View
NCT00042003 Astex Pharmaceuticals, Inc. COMPLETED Phase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Blast Phase Who Are Refractory to Imatinib Mesylate (Gleevec) PHASE2 View
NCT00041951 Icahn School of Medicine at Mount Sinai COMPLETED Search for Genes Influencing Childhood Absence Epilepsy (CAE) Study View
NCT00041860 Positive Gene Therapy National Institute of Environmental Health Sciences (NIEHS) COMPLETED Modulation of Benzene Metabolism by Exposure to Environment NA View
NCT00041834 Positive Gene Therapy National Institute of Environmental Health Sciences (NIEHS) COMPLETED Geographic Modeling of Traffic and Asthma Rates View
NCT00041795 NeoTherapeutics COMPLETED Neotrofin for Treatment of Chemotherapy-Induced Peripheral Neuropathy PHASE2 View
NCT00041769 National Institute of Allergy and Infectious Diseases (NIAID) COMPLETED Using Drug Levels in the Blood to Guide Therapy in HIV Infected Patients Taking a Protease Inhibitor PHASE3 View
NCT00041756 Procter and Gamble COMPLETED Efficacy and Safety of PG-530742 in the Treatment of Mild to Moderate Knee Osteoarthritis PHASE2 View
NCT00041704 Pfizer COMPLETED The Safety and Efficacy of Intravenous Anidulafungin as a Treatment for Azole-Refractory Mucosal Candidiasis (FRMC) PHASE2 View
NCT00041561 Mallinckrodt TERMINATED Effects of Inhaled Nitric Oxide in the Treatment of Acute Hypoxemic Respiratory Failure (AHRF) in Pediatrics PHASE3 View
NCT00041535 Positive Gene Therapy National Institute of Neurological Disorders and Stroke (NINDS) COMPLETED OGT 918-006: A Phase I/II Randomized, Controlled Study of OGT 918 in Patients With Neuronopathic Gaucher Disease PHASE2 View
NCT00041457 Brigham and Women's Hospital COMPLETED Epidemiology of Venous Thromboembolism View
NCT00041418 National Heart, Lung, and Blood Institute (NHLBI) COMPLETED Cardiac MR of Subclinical CVD: Impact of Age View
NCT00041405 National Heart, Lung, and Blood Institute (NHLBI) COMPLETED Mechanisms of Pro-Thrombosis in Diabetes Mellitus -- Ancillary to BARI 2D View
NCT00041392 Duke University COMPLETED Effects of Magnesium on Individuals Undergoing Coronary Artery Bypass Graft Surgery PHASE2 View
NCT00041327 AIDS Malignancy Consortium COMPLETED Combination Chemotherapy Followed By Antiviral Therapy and Interferon Alfa in Treating Patients With HTLV-1-Related Adult T-Cell Leukemia/Lymphoma PHASE2 View
NCT00041132 SWOG Cancer Research Network COMPLETED S0213 Chemotherapy Plus Rituximab in Treating Patients With Mantle Cell Lymphoma PHASE2 View
NCT00041106 National Cancer Institute (NCI) COMPLETED Gefitinib Plus Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Bladder Cancer PHASE2 View
NCT00041093 Gynecologic Oncology Group COMPLETED Docetaxel in Treating Patients With Persistent or Recurrent Cervical Cancer PHASE2 View
NCT00041067 SWOG Cancer Research Network COMPLETED S0215 Trastuzumab, Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer PHASE2 View
NCT00040950 Jonsson Comprehensive Cancer Center COMPLETED Biological Therapy Plus Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma PHASE1 View
NCT00040859 Alliance for Clinical Trials in Oncology COMPLETED Oxaliplatin and Capecitabine in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer PHASE2 View
NCT00040833 Positive Gene Therapy Memorial Sloan Kettering Cancer Center COMPLETED Acupuncture and Acupressure in Treating Patients With Moderate or Severe Pain Related to Stage III or Stage IV Pancreatic Cancer PHASE2 View
NCT00040820 Roswell Park Cancer Institute COMPLETED Oxaliplatin in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal Cancer NA View
NCT00040794 National Cancer Institute (NCI) COMPLETED Combination Chemotherapy, Radiation Therapy, and Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer PHASE2 View
NCT00040768 National Cancer Institute (NCI) TERMINATED Bortezomib in Treating Patients With Advanced Non-small Cell Lung Cancer PHASE2 View
NCT00040651 National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) TERMINATED Safety and Value of Self Bone Marrow Transplants Following Chemotherapy in Scleroderma Patients PHASE1 View
NCT00040560 Copharos UNKNOWN Study of 111In-DAC as an Medical Imaging Agent for Lung Cancer and Brain Cancer Consistent With Metastatic Lung Cancer PHASE1 View
NCT00040534 Positive Gene Therapy Merck Sharp & Dohme LLC TERMINATED Safety and Tolerability Study of Farnesyl Protein Transferase Inhibitor in Combination With Gemcitabine and Cisplatin in Advanced Cancer (Study P01499)(TERMINATED) PHASE1 View
NCT00040495 Wyeth is now a wholly owned subsidiary of Pfizer COMPLETED Study Evaluating Pantoprazole in Peptic Ulcer Hemorrhage PHASE3 View
NCT00040469 Baylor College of Medicine TERMINATED Bone Marrow Transplant From Related Donor for Patients With High Risk Hemoglobinopathies PHASE2 View
NCT00040456 Baylor College of Medicine TERMINATED Oral Magnesium Pidolate, Hemoglobin SC Disease, MG Pidolate PHASE2 View
NCT00040404 Cephalon TERMINATED Safety and Efficacy Study of CEP-1347 in the Treatment of Parkinson's Disease PHASE2 View
NCT00040261 National Institute of Mental Health (NIMH) COMPLETED Clinical Trial of Memantine for Major Depression PHASE3 View
NCT00040235 National Institutes of Health Clinical Center (CC) COMPLETED Magnesium Effects in Apheresis PHASE3 View
NCT00040157 Alexion Pharmaceuticals, Inc. TERMINATED Safety and Antiviral Study of ACH-126, 443 (Beta-L-Fd4C) in the Treatment of Adults With HIV Infection and Modestly Detectable Viral Load. PHASE2 View
NCT00040105 M.D. Anderson Cancer Center COMPLETED Zarnestra and Gleevec in Chronic Phase Chronic Myelogenous Leukemia PHASE1 View
NCT00040092 Aptose Biosciences Inc. COMPLETED A Study to Test the Effectiveness of Virulizin® Given in Combination With Standard Chemotherapy for Pancreatic Cancer PHASE3 View
NCT00040066 National Institute on Drug Abuse (NIDA) UNKNOWN Development of Human Laboratory Study Model of Cocaine Relapse Prevention. - 1 PHASE1 View
NCT00039858 Encysive Pharmaceuticals COMPLETED Evaluation of Argatroban Injection in Pediatric Patients Requiring Anticoagulant Alternatives to Heparin PHASE4 View
NCT00039832 National Institute of Neurological Disorders and Stroke (NINDS) COMPLETED ReoPro and Retavase to Restore Brain Blood Flow After Stroke PHASE2 View
NCT00039793 National Center for Complementary and Integrative Health (NCCIH) COMPLETED Massage Therapy for Cancer-Related Fatigue PHASE2 View
NCT00039767 National Institutes of Health Clinical Center (CC) COMPLETED Heparin Versus Lepirudin Flushes in Preventing Blockage of Venous Access Devices PHASE2 View
NCT00039702 National Institute of Mental Health (NIMH) COMPLETED Brain Imaging in Alzheimer's Disease View
NCT00039650 National Institutes of Health Clinical Center (CC) COMPLETED Pilot Study: Effects of G-CSF on T Cell Function View
NCT00039559 Massachusetts General Hospital UNKNOWN Clinical Trial to Screen Participants Who Are at High Genetic Risk for Ovarian Cancer NA View
NCT00039520 Fox Chase Cancer Center COMPLETED Sulindac and Docetaxel in Treating Women With Metastatic or Recurrent Breast Cancer PHASE2 View
NCT00039494 National Cancer Institute (NCI) COMPLETED Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors PHASE2 View
NCT00039468 Dartmouth-Hitchcock Medical Center COMPLETED Thalidomide and Irinotecan in Treating Patients With Glioblastoma Multiforme Who Have Undergone Radiation Therapy PHASE2 View
NCT00039403 National Cancer Institute (NCI) COMPLETED UCN-01 and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer PHASE1 View
NCT00039351 European Organisation for Research and Treatment of Cancer - EORTC COMPLETED Combination Chemotherapy in Treating Older Patients With Non-Hodgkin's Lymphoma PHASE2 View
NCT00039234 Maxim Pharmaceuticals UNKNOWN Interleukin-2 With or Without Histamine Dihydrochloride in Treating Patients With Stage IV Melanoma Metastatic to the Liver PHASE3 View
NCT00039195 Memorial Sloan Kettering Cancer Center COMPLETED Chemotherapy and Rituximab With or Without Total-Body Irradiation and Peripheral Stem Cell Transplant in Treating Patients With Lymphoma PHASE2 View
NCT00039169 Theradex UNKNOWN BAY 59-8862 in Treating Patients With Advanced Kidney Cancer PHASE2 View
NCT00039156 Theradex UNKNOWN BAY 59-8862 in Treating Patients With Refractory Non-Hodgkin's Lymphoma PHASE2 View
NCT00039104 National Cancer Institute (NCI) COMPLETED Zoledronate and BMS-275291 in Treating Patients With Prostate Cancer PHASE2 View
NCT00038961 GlaxoSmithKline COMPLETED A Study to Evaluate the Efficacy and Safety of Fondaparinux Sodium When Used With Intermittent Pneumatic Compression to Prevent Venous Thromboembolic (IPC) Versus IPC Alone for the Prevention of Venous Thromboembolic Events in Subjects at Increased Risk Undergoing Major Abdominal Surgery (APOLLO). PHASE3 View
NCT00038935 Wyeth is now a wholly owned subsidiary of Pfizer COMPLETED Study Evaluating BDDRFVIII and ReFacto AF in Hemophilia A PHASE3 View
NCT00038857 M.D. Anderson Cancer Center COMPLETED Megadose CD34 Selected Progenitor Cells for Transplantation in Patients With Advanced Hematological Malignant Diseases PHASE2 View
NCT00038818 M.D. Anderson Cancer Center TERMINATED CD8 DLI for Patients With Relapse or Residual Disease Following Allogeneic Stem Cell Transplantation NA View
NCT00038805 Positive Gene Therapy M.D. Anderson Cancer Center TERMINATED Nonmyeloablative Preparative Regimen Using Mylotarg for Patients With High Risk Acute Myeloid Leukemia (AML), Acute Lymphocytic Leukemia (ALL), Chronic Myeloid Leukemia (CML) and Myelodysplastic Syndrome (MDS) PHASE2 View
NCT00038792 M.D. Anderson Cancer Center TERMINATED Phase I/II Trial rHuKFG for the Treatment of Steroid Refractory Gastrointestinal Acute GVHD PHASE1 View
NCT00038766 Ferring Pharmaceuticals TERMINATED CNI-1493 for Treatment of Moderate to Severe Crohn's Disease PHASE2 View
NCT00038727 National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) UNKNOWN Diabetes Prevention Program Outcomes Study PHASE3 View
NCT00038558 M.D. Anderson Cancer Center COMPLETED Prophylactic Use of Filgrastim SD/01 in Patients With Hodgkin's Disease Receiving ABVD Chemotherapy PHASE3 View
NCT00038532 Positive Gene Therapy Abbott COMPLETED Amprenavir/Ritonavir, Saquinavir/Ritonavir or Efavirenz in HIV-Infected Subjects Following Failure With Kaletra (ABT-378/Ritonavir) as Their First Protease Inhibitor Based HAART PHASE2 View
NCT00038506 ViiV Healthcare COMPLETED Study Of Investigational Regimen Combining FDA Approved HIV Drugs In HIV Subjects Experiencing Early Virologic Failure PHASE4 View
NCT00038493 M.D. Anderson Cancer Center COMPLETED Temozolomide and SCH66336 for Recurrent Glioblastoma Multiforme PHASE2 View
NCT00038467 Pfizer COMPLETED Randomized Trial Of Exemestane Versus Continued Tamoxifen In Postmenopausal Women With Early Breast Cancer PHASE3 View
NCT00038402 M.D. Anderson Cancer Center COMPLETED Evaluation of the Addition of Herceptin to Standard Chemotherapy in the Neoadjuvant Setting for Operable Breast Cancer PHASE3 View
NCT00038350 US Department of Veterans Affairs COMPLETED Effects of Age and Age-Related Diseases on Swallowing PHASE2 View
NCT00038259 Positive Gene Therapy National Institute of Allergy and Infectious Diseases (NIAID) COMPLETED Interleukin-2 (IL-2) Treatment for HIV Infected Patients Who Have Interrupted Their Anti-HIV Drug Therapy NA View
NCT00038233 M.D. Anderson Cancer Center COMPLETED Thalidomide for Multiple Myeloma PHASE3 View
NCT00038220 Abbott COMPLETED Effectiveness of ABT-378/Ritonavir Plus Lamivudine Plus Efavirenz Plus Tenofovir DF in HIV-Infected Patients PHASE2 View
NCT00038194 M.D. Anderson Cancer Center COMPLETED Phase I Trial of Fixed Dose STI571 (Imatinib Mesylate) With Escalating Doses of Docetaxel in Patients With Metastatic Androgen-Independent Prostate Cancer PHASE1 View
NCT00038168 M.D. Anderson Cancer Center COMPLETED Intravenous Estramustine With Taxol in Hormone Refractory Prostate Adenocarcinoma PHASE1 View
NCT00038103 Pfizer COMPLETED Open-Label Study Of Exemestane With Or Without Celecoxib In Postmenopausal Women With ABC Having Progressed On Tamoxifen PHASE2 View
NCT00038051 M.D. Anderson Cancer Center COMPLETED Evaluation of the Anti-CD-33 Immunotoxin Hum-195/rGel in Patients With Advanced Myeloid Malignancies PHASE1 View
NCT00038012 M.D. Anderson Cancer Center COMPLETED rhTPO Mobilized Auto Cryo Platelets For GYN Patients Receiving Carboplatin NA View
NCT00037960 Positive Gene Therapy US Department of Veterans Affairs COMPLETED Automated Constraint-Induced Therapy for Restoring Movement After Stroke PHASE2 View
NCT00037934 US Department of Veterans Affairs COMPLETED Robotic Upper-Limb Neurorehabilitation in Chronic Stroke Patient PHASE2 View
NCT00037895 US Department of Veterans Affairs COMPLETED Stroke Rehabilitation Outcomes With Supported Treadmill Ambulation Training PHASE2 View
NCT00037869 M.D. Anderson Cancer Center COMPLETED High Dose I-131 Metaiodobenzylguanidine(MIBG) for Metastatic Neuroendocrine Tumors PHASE3 View
NCT00037804 Pfizer COMPLETED Irinotecan in Treating Patients With Refractory Solid Tumors and Liver Dysfunction PHASE1 View
NCT00037661 Merck Sharp & Dohme LLC COMPLETED Study of INS365 Ophthalmic Solution in a Controlled Adverse Environment in Patients With Dry Eye PHASE3 View
NCT00037635 Positive Gene Therapy Amgen COMPLETED A Study of an Investigational Medication for the Treatment of Secondary Hyperparathyroidism in Dialysis Patients PHASE3 View
NCT00037557 Positive Gene Therapy Wyeth is now a wholly owned subsidiary of Pfizer COMPLETED Study Evaluating rFIX; BeneFIX in Severe Hemophilia B PHASE3 View
NCT00037518 Amgen COMPLETED A Study of an Investigational Medication for Severe Primary Hyperparathyroidism or Parathyroid Cancer PHASE4 View
NCT00037505 National Center for Research Resources (NCRR) COMPLETED Major Depression and Inflammatory Risk Markers for Coronary Heart Disease View
NCT00037492 National Institute of Neurological Disorders and Stroke (NINDS) COMPLETED Families In Recovery From Stroke Trial (F.I.R.S.T.) PHASE3 View
NCT00037466 Boston Children's Hospital COMPLETED Relation of Diet to Serum Homocysteine Level in Youths View
NCT00037427 National Heart, Lung, and Blood Institute (NHLBI) COMPLETED Airway Responses Following Chlorine Gas Exposure View
NCT00037258 Brigham and Women's Hospital COMPLETED Dyslipidemia and Risk of Cardiovascular Disease in Diabetic Men and Women View
NCT00037232 National Heart, Lung, and Blood Institute (NHLBI) COMPLETED Failure Time Methods for Family Disease Studies View
NCT00037206 Pfizer COMPLETED A Safety & Effectiveness Study of Intravenous Anidulafungin With AmBisome® for Treatment of Invasive Aspergillosis (IA). PHASE2 View
NCT00037193 National Center for Research Resources (NCRR) COMPLETED Acute Regulation of Parathyroid Hormone by Dietary Phosphate View
NCT00037167 National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) COMPLETED Effects of Exercise Poles on Older Adults During Exercise Walking PHASE1 View
NCT00037128 Genelabs Technologies UNKNOWN Study of GL701 in Men With Systemic Lupus Erythematosus PHASE3 View
NCT00037102 MidAmerica Neuroscience Research Foundation at Rowe Neurology Institute COMPLETED Combination Therapy With Avonex and BiMonthly High Dose Intravenous Methotrexate in Multiple Sclerosis PHASE4 View
NCT00037050 Positive Gene Therapy Pfizer COMPLETED Antibiotic Treatment for Infections of Short Term In-dwelling Vascular Catheters Due to Gram Positive Bacteria PHASE3 View
NCT00036959 National Institutes of Health Clinical Center (CC) COMPLETED ABT-751 in Treating Young Patients With Refractory Solid Tumors PHASE1 View
NCT00036933 Memorial Sloan Kettering Cancer Center COMPLETED Vaccine Therapy Plus QS21 in Treating Patients With Prostate Cancer PHASE1 View
NCT00036920 Memorial Sloan Kettering Cancer Center COMPLETED TLK286 in Treating Patients With Advanced Non-Small Cell Lung Cancer PHASE2 View
NCT00036894 National Cancer Institute (NCI) COMPLETED CC-5013 in Treating Patients With Recurrent Glioma PHASE1 View
NCT00036868 European Organisation for Research and Treatment of Cancer - EORTC COMPLETED Combination Chemotherapy With Trastuzumab in Treating Women With Metastatic Breast Cancer PHASE2 View
NCT00036751 National Cancer Institute (NCI) COMPLETED Imatinib Mesylate in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer PHASE2 View
NCT00036660 NCIC Clinical Trials Group COMPLETED SarCNU in Treating Patients With Recurrent Malignant Glioma PHASE2 View
NCT00036634 Gilead Sciences COMPLETED A Dose Escalation Study of Tenofovir Alafenamide in Treatment-Naive Patients PHASE1 View
NCT00036595 National Institute of Neurological Disorders and Stroke (NINDS) COMPLETED Functional Coupling of Cortico-Cortical and Cortico-Muscular Connections During Motor Movements: An Electrocorticographic Study of Ipsilateral Motor Control View
NCT00036569 National Cancer Institute (NCI) COMPLETED A Phase II Study of Pegylated Interferon Alfa 2b (PEG-Intron(Trademark)) in Children With Diffuse Pontine Gliomas PHASE2 View
NCT00036556 Abbott COMPLETED Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Cancer PHASE3 View
NCT00036504 Eli Lilly and Company COMPLETED Efficacy and Safety of Twice-Daily Insulin Lispro Low Mixture Compared to a Once-Daily Long Acting Insulin Comparator in Patients Who Have Been Using One or More Oral Antihyperglycemic Agents Without Insulin PHASE4 View
NCT00036361 Otsuka Pharmaceutical Development & Commercialization, Inc. COMPLETED Broad Effectiveness: Study With Aripiprazole PHASE3 View
NCT00036335 Eli Lilly and Company COMPLETED Subject Information and Consent Form F1J-US-HMCB Duloxetine Once-Daily Dosing Versus Placebo in Patients With Major Depression and Pain PHASE3 View
NCT00036257 Astellas Pharma Inc COMPLETED Dose-Escalating and Safety Study of CP-461 in Patients With Chronic Lymphocytic Leukemia PHASE1 View
NCT00036218 Pfizer COMPLETED Study Evaluating Sumanirole for the Treatment of the Signs and Symptoms of Early Parkinson's Disease. PHASE3 View
NCT00036205 Pfizer TERMINATED Open Label Sumanirole Study of Safety, Tolerability, and Therapeutic Response In Patients With Parkinson's Disease PHASE3 View
NCT00036192 Astellas Pharma Inc COMPLETED Trial of FK614 in Type 2 Diabetics Inadequately Controlled on a Sulfonylurea PHASE2 View
NCT00036166 Positive Gene Therapy Astellas Pharma Inc COMPLETED Study of FK463 for the Treatment of Invasive Aspergillosis PHASE2 View
NCT00035958 Children's Hospital Medical Center, Cincinnati TERMINATED Understanding the Pathogenesis and Treatment of Childhood Onset Dermatomyositis PHASE2 View
NCT00035932 Bristol-Myers Squibb COMPLETED Atazanavir (BMS-232632) in Combination With Ritonavir or Saquinavir, and Lopinavir/Ritonavir, Each With Tenofovir and a Nucleoside in Subjects With HIV PHASE3 View
NCT00035893 AIM ImmunoTech Inc. COMPLETED The Role of Ampligen in Strategic Therapeutic Intervention (STI) of HAART PHASE2 View
NCT00035867 Telik COMPLETED Study of TLK199 HCl Liposomes for Injection in Myelodysplastic Syndrome PHASE1 View
NCT00035802 Johnson & Johnson Pharmaceutical Research & Development, L.L.C. COMPLETED A Study to Evaluate the Safety and Effectiveness of Topiramate Compared to Placebo in the Treatment of Patients With Bipolar I Disorder PHASE3 View
NCT00035750 University of Wisconsin, Madison COMPLETED Risk Factors for Atherogenesis in Type 1 Diabetes View
NCT00035659 Rush University Medical Center COMPLETED Longitudinal Study of the Menopause and Fat Patterning View
NCT00035633 Positive Gene Therapy Bristol-Myers Squibb COMPLETED A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Positive for Hepatitis B E Antigen PHASE3 View
NCT00035620 Amgen COMPLETED Pegfilgrastim as Support to Pediatric Sarcoma Patients Receiving Chemotherapy PHASE2 View
NCT00035594 Amgen COMPLETED Pegfilgrastim as Support to Advanced Breast Cancer Patients Receiving Chemotherapy PHASE3 View
NCT00035568 Positive Gene Therapy Bristol-Myers Squibb COMPLETED A Research Study to Assess the Mechanism By Which Glucovance, Metformin, and Glyburide Work To Control Glucose Levels In Patients With Type 2 Diabetes PHASE4 View
NCT00035503 Teva Branded Pharmaceutical Products R&D, Inc. COMPLETED Multicenter Trial For Patients With Acute Crohn's Disease PHASE2 View
NCT00035451 Forest Laboratories COMPLETED Efficacy and Safety Evaluation of Azimilide or Sotalol vs Placebo for Treatment of Patients With Atrial Fibrillation. PHASE3 View
NCT00035360 Merck Sharp & Dohme LLC COMPLETED Phase III PEG-Intron in HIV-infected Patients (Study P00738) PHASE3 View
NCT00035334 Bellus Health Inc. - a GSK company COMPLETED Study of the Safety and Efficacy of NC-503 in Secondary (AA) Amyloidosis PHASE2 View
NCT00035295 Merck Sharp & Dohme LLC COMPLETED Treatment of Patients With Major Depressive Disorder With MK0869 (0869-061) PHASE3 View
NCT00035269 Pfizer COMPLETED New Antibiotic to Treat Patients With Community-acquired Pneumonia Due to a Specific Bacteria (S. Pneumoniae Pneumonia) PHASE3 View
NCT00035256 Eli Lilly and Company COMPLETED Sequential Use of Teriparatide and Raloxifene HCl in the Treatment of Postmenopausal Women With Osteoporosis PHASE4 View
NCT00035204 Johnson & Johnson Pharmaceutical Research & Development, L.L.C. COMPLETED A Study of the Effects on Sleep, Attention, and Gastrointestinal Tolerance of Galantamine and Donepezil in Patients With Alzheimer's Disease PHASE4 View
NCT00035061 Eli Lilly and Company COMPLETED A Phase 2 Trial of ALIMTA (Pemetrexed) in Locally Advanced or Metastatic Recurrent Transitional Cell Carcinoma of the Urothelium PHASE2 View
NCT00035035 Eli Lilly and Company COMPLETED A Phase 3 Trial of ALIMTA (LY231514, Pemetrexed) Plus GEMZAR Versus GEMZAR in Patients With Unresectable or Metastatic Cancer of the Pancreas. PHASE3 View
NCT00034957 Pfizer COMPLETED Study of the Efficacy of an Investigational Drug in Adult Patients With Non Small-Cell Lung Cancer (NSCLC) PHASE2 View
NCT00034918 Genzyme, a Sanofi Company COMPLETED This Study is to Assess the Efficacy and Safety of ZD6474 in Subjects With Metastatic Breast Cancer PHASE2 View
NCT00034905 AstraZeneca COMPLETED A Comparison of Seroquel vs. Risperidone in Schizophrenia PHASE4 View
NCT00034892 Positive Gene Therapy AstraZeneca COMPLETED CAFE Comparison of Atypicals in First Episode of Psychosis PHASE3 View
NCT00034866 Boehringer Ingelheim COMPLETED Dose Ranging Trial of Tipranavir/Ritonavir in Treatment-Experienced HIV Infected Individuals PHASE2 View
NCT00034658 Merck Sharp & Dohme LLC COMPLETED Open Label Study of Posaconazole in the Treatment of Invasive Fungal Infections (Study P00041) PHASE3 View
NCT00034632 Merck Sharp & Dohme LLC COMPLETED Study of Posaconazole in the Treatment of Invasive Fungal Infections (Study P02095) PHASE3 View
NCT00034606 Eli Lilly and Company COMPLETED Comparing 3 Schedules of Alimta Plus Gemzar PHASE2 View
NCT00034593 Eli Lilly and Company COMPLETED A Phase 2 Trial of ALIMTA (Pemetrexed) Plus Gemcitabine in Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium PHASE2 View
NCT00034567 National Institute on Aging (NIA) COMPLETED Healthy Aging and Memory Study View
NCT00034528 National Institute of Allergy and Infectious Diseases (NIAID) TERMINATED Stem Cell Transplantation After Reduced-Dose Chemotherapy for Patients With Sickle Cell Disease or Thalassemia PHASE2 View